{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:34:30Z","timestamp":1790616870204,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tryptophan metabolism is strongly associated with immunosuppression and may influence lung adenocarcinoma prognosis as well as tumor microenvironment alterations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sequencing datasets were obtained from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. Two different clusters were identified by consensus clustering, and prognostic models were established based on differentially expressed genes (DEGs) in the two clusters. We investigated differences in mutational landscapes, enrichment pathways, immune cell infiltration, and immunotherapy between high- and low-risk scoring groups. Single-cell sequencing data from Bischoff et\u00a0al. were used to identify and quantify tryptophan metabolism, and model genes were comprehensively analyzed. Finally, PTTG1 was analyzed at the pan-cancer level by the pan-TCGA cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Risk score was defined as an independent prognostic factor for lung adenocarcinoma and was effective in predicting immunotherapy response in patients with lung adenocarcinoma. PTTG1 is one of the key genes, and knockdown of PTTG1 <jats:italic>in vitro<\/jats:italic> decreases lung adenocarcinoma cell proliferation and migration and promotes apoptosis and down-regulation of tryptophan metabolism regulators in lung adenocarcinoma cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our study revealed the pattern and molecular features of tryptophan metabolism in lung adenocarcinoma patients, established a model of tryptophan metabolism-associated lung adenocarcinoma prognosis, and explored the roles of PTTG1 in lung adenocarcinoma progression, EMT process, and tryptophan metabolism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1386427","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T04:27:57Z","timestamp":1722400077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1"],"prefix":"10.3389","volume":"15","author":[{"given":"Ziqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiluo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.12916","article-title":"Epidemiology of lung cancer in China","volume":"10","author":"Cao","year":"2019","journal-title":"Thorac Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","article-title":"Cell death-based treatment of lung adenocarcinoma","volume":"9","author":"Denisenko","year":"2018","journal-title":"Cell Death Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0042","article-title":"Pituitary tumor-transforming gene: physiology and implications for tumorigenesis","volume":"28","author":"Vlotides","year":"2007","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201303698","article-title":"Biology, detection, and clinical implications of circulating tumor cells","volume":"7","author":"Joosse","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107458","article-title":"Circulating tumor DNA as an early cancer detection tool","volume":"207","author":"Campos-Carrillo","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.34739","article-title":"Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications","volume":"16","author":"Zito Marino","year":"2019","journal-title":"Int J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.01.003","article-title":"Dysregulation of metabolic enzymes in tumor and stromal cells: role in oncogenesis and therapeutic opportunities","volume":"473","author":"Khan","year":"2020","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.011","article-title":"The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy","volume":"76","author":"Brochez","year":"2017","journal-title":"Eur J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cytogfr.2017.05.004","article-title":"Amino-acid sensing and degrading pathways in immune regulation","volume":"35","author":"Grohmann","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1988","article-title":"A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase sirna","volume":"15","author":"Yen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113873109","article-title":"Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase","volume":"109","author":"Pilotte","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms21124414","article-title":"Immuno-metabolism and microenvironment in cancer: key players for immunotherapy","volume":"21","author":"Giannone","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"Ido in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12967-018-1595-3","article-title":"Can ido activity predict primary resistance to anti-pd-1 treatment in nsclc","volume":"16","author":"Botticelli","year":"2018","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.1.0225","article-title":"Structure, expression, and function of human pituitary tumor-transforming gene (Pttg)","volume":"13","author":"Zhang","year":"1999","journal-title":"Mol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3507436","article-title":"Prognostic significance of pttg1 and its methylation in lung adenocarcinoma","volume":"2022","author":"Bai","year":"2022","journal-title":"J Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"Pttg1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.337428","article-title":"Pttg1 oncogene promotes tumor Malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population","volume":"287","author":"Yoon","year":"2012","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy207","article-title":"Ect2\/psmd14\/pttg1 axis promotes the proliferation of glioma through stabilizing E2f1","volume":"21","author":"Zhi","year":"2019","journal-title":"Neuro Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt158","article-title":"Pttg1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by Mir-186","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0306419015572073","article-title":"Knockdown of Pttg1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of Tgfb1\/Smad3 signaling","volume":"28","author":"Li","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02054-3","article-title":"Single-cell Rna sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma","volume":"40","author":"Bischoff","year":"2021","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (Msigdb) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz210","article-title":"Tisidb: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti422","article-title":"Penalized cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data","volume":"21","author":"Gui","year":"2005","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx518","article-title":"Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase ii imvigor210 study","volume":"28","author":"Necchi","year":"2017","journal-title":"Ann Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3762","article-title":"Predictive gene signature in mage-A3 antigen-specific cancer immunotherapy","volume":"31","author":"Ulloa-Montoya","year":"2013","journal-title":"J Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-pd-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp Mol Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discovery"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond ido and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002840","article-title":"Tryptophan potentiates cd8(+) T cells against cancer cells by trip12 tryptophanylation and surface pd-1 downregulation","volume":"9","author":"Qin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.celrep.2018.03.026","article-title":"Shp-2 is dispensable for establishing T cell exhaustion and for pd-1 signaling in vivo","volume":"23","author":"Rota","year":"2018","journal-title":"Cell Rep"},{"key":"B51","article-title":"Pd-1\/pd-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0756-0","article-title":"Fbxo38 mediates pd-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.783495","article-title":"Clinical significance and immunometabolism landscapes of a novel recurrence-associated lipid metabolism signature in early-stage lung adenocarcinoma: A comprehensive analysis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012143","article-title":"A metabolism-related gene prognostic index for prediction of response to immunotherapy in lung adenocarcinoma","volume":"23","author":"Tang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"Gistic2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"15198","DOI":"10.1038\/s41598-023-42541-z","article-title":"Predicting lung adenocarcinoma prognosis, immune escape, and pharmacomic profile from arginine and proline-related genes","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2019.4970","article-title":"Fam83a is a prognosis signature and potential oncogene of lung adenocarcinoma","volume":"39","author":"Yu","year":"2020","journal-title":"DNA Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.723172","article-title":"Signatures of multi-omics reveal distinct tumor immune microenvironment contributing to immunotherapy in lung adenocarcinoma","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1156230","article-title":"Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Genet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002157","article-title":"Follicular helper-T cells restore Cd8(+)-dependent antitumor immunity and anti-Pd-L1\/Pd-1 efficacy","volume":"9","author":"Niogret","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cllc.2017.02.001","article-title":"Immune checkpoint inhibitors for patients with advanced non-small-cell lung cancer: A systematic review","volume":"18","author":"Ellis","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in Pd-L1\/Pd-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123605","article-title":"Immune escape mechanisms in non small cell lung cancer","volume":"12","author":"Anichini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653208","article-title":"Amino acid trp: the far out impacts of host and commensal tryptophan metabolism","volume":"12","author":"Grifka-Walk","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001628","article-title":"Ido upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673293414240314043529","article-title":"Identification and verification of metabolism-related immunotherapy features and prognosis in lung adenocarcinoma","volume":"6","author":"Luo","year":"2024","journal-title":"Curr Med Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.01.005","article-title":"A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells","volume":"46","author":"Mondanelli","year":"2017","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of kras-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discovery"},{"key":"B74","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960738","article-title":"Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12967-019-02173-2","article-title":"Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma","volume":"17","author":"Zhang","year":"2019","journal-title":"J Transl Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115272","article-title":"By integrating single-cell rna-seq and bulk rna-seq in sphingolipid metabolism, cacybp was identified as a potential therapeutic target in lung adenocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","article-title":"Integrative proteomic characterization of human lung adenocarcinoma","volume":"182","author":"Xu","year":"2020","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v15i19","article-title":"The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy","volume":"15","author":"Zhang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1277530","article-title":"Deciphering treg cell roles in esophageal squamous cell carcinoma: A comprehensive prognostic and immunotherapeutic analysis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18284","article-title":"Purine metabolism in lung adenocarcinoma: A single-cell analysis revealing prognostic and immunotherapeutic insights","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1386427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T04:28:00Z","timestamp":1722400080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1386427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":81,"alternative-id":["10.3389\/fimmu.2024.1386427"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1386427","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"article-number":"1386427"}}